Suture material is a potential risk factor for the occurrence of an SSI because the suture can become colonized by microorganisms at a surgical site. PLUS ® Sutures are sutures coated with an antibacterial agent, Triclosan. They have been developed with the objective of preventing the bacterial colonization on the suture. Diverse studies, and in particular a meta-analysis, has shown that PLUS ® Sutures can reduce the risk of a SSI by 30%.
The aim of this study is to analyze the economic impact of using PLUS ® Sutures vs. conventional sutures with respect to SSI by reducing the risk of bacterial colonization of the suture, from a Spanish hospital perspective.
BACKGROUND/OBJECTIVES
A dynamic excel-based decision-analytic budget impact model was developed. The two main variables considered for the sensitivity analysis were the rate of reduction of the SSI (30%, ±95% CI in 5% increments) and the difference in price between PLUS ® Suture and conventional suture. There is an additional variable considered, the cost of an SSI per patient in a Spanish Hospital. The difference between one approximation (10,113€, Alfonso 2007) and the other (9,657€, Aullé 2014) is minimal.
An estimation of the number of patients that undergo surgery in a midsized hospital was used by taking values for 6 of such hospitals, and calculating an average, resulting in 20,216 patients a year. Only one year horizon was considered in this case, because the assumption is that this technology replaces the previous one.
A two-way sensitivity analysis was conducted. Number of sutures used in a surgery was not included as this did not change the results. A 95%CI variation was chosen for the rate of infection, with the average being 70% and in increments of 5%. For the differential cost between a PLUS ® vs a conventional suture, a range between 0,50€ and 3,00€ was used, in increments of 0,5€, with the average being a difference of 2,0€ between the two suture prices. This generated 42 different scenarios for the sensitivity analysis (Table 2) . The sensitivity analysis showed that there were cost savings in using PLUS® vs conventional suture in 100% of the scenarios. The budget impact for each of the 42 different scenarios are shown numerically and graphically in Figure 3 . As can be observed, the model is robust against variations of the base cases for the key variables, suture cost differential and reduction in SSI rates. It should be noted that as can be shown in Figure 3 , the cost differential does not considerably affect cost savings in the ranges studied; however the variable that does affect the cost savings considerably is the reduction rate in surgical site infection. This is understandable, as the scale is significantly different: eurocents vs thousands of euros. 
METHODS

RESULTS (continued)
The budget impact analysis may be useful when deciding for inclusion or reassessment of technologies. This analysis adds new evidence of support for the use of PLUS® vs conventional suture by demonstrating that it has a more favorable economic impact due to the reduction in risk of patients developing a surgical site infection. The use of PLUS® suture led to savings of 24% for a medium-sized Spanish hospital, resulting in 5.3M€ annual savings. Reducing surgical site infections is not only a cost issue, as it is related to other comorbidities, pain, suffering and mortality; hence improving patient outcomes and quality of healthcare delivery, while reducing costs.
CONCLUSIONS RESULTS
A 23,64% budget impact decrease was achieved by using PLUS® vs conventional sutures, leading to 5,3M€ in savings that year. The more costly suture was largely compensated by the reduction in patients suffering from SSI and their related costs (Table 1 and Figure 1) . 
